Green Mountain Health Alliance Ltd. (“Green Mountain”, “GMHA” or the “Company”), an upcoming, large-scale, low-cost, quality medical cannabis wholesaler, is pleased to announce that it is proceeding with the planned construction of its cannabis facility located at 760 Highway 3A, Kaleden, BC.

The resumption of work comes as a result of ongoing discussion with the Agricultural Land Commission (“ALC”) and the receipt of a File Closure Letter from the ALC. After multiple property inspections taking place on August 15 and September 4, 2018, the ALC stated in a letter dated September 17, 2018, that they are “satisfied that the activity on the Property is in compliance with the Agricultural Land Commission legislation at this time.” The Company is currently a privately held entity and holds an application for a license under the Access to Cannabis for Medical Purposes Regulations (Canada) (“ACMPR”).


“We were ready to forge ahead with construction plans for our two-level administrative and nursery facility on Highway 3A when ALC regulations unexpectedly changed mid-July,” says company President, Wade Attwood. “With these legislative changes, our existing building design was considered ‘non-farm use’ under the new ALC regulations. We have since redesigned our buildings to meet our goals and also to comply with the new ALC ‘farm-use’ regulations.”

With a mission to cultivate large-scale, low-cost, high-quality medical cannabis, Green Mountain Health Alliance has secured two properties; one of which is a wholly owned 16-acre parcel on the Agricultural Land Reserve (ALR) in Kaleden, British Columbia.

“After the ALC’s new legislation was tabled, we have taken the time to discuss the changes with ALC officials, examine our company goals, and modify our plans to be in full compliance with the new regulations,” states Attwood. “From the start, our business model has centered on greenhouse growing, capitalizing on the abundant natural sunshine in the Okanagan Valley. We never intended on building ‘concrete bunkers’ for indoor cannabis production on ALR land, so modifying our plans was rather easy and will reduce construction costs in the long run.”

The company’s facility is planned with environmental sustainability and technology in mind and includes year-round rainwater capture and storage, closed-loop nutrient systems, and odour control mechanisms.

Attwood further states that “Our greenhouse facility will be state of the art and suitable to grow a variety of crops now and in the future, whether that is tomatoes, basil, or medical cannabis. We are looking forward to producing a high-quality medicinal product with great promise for many health conditions, all while creating jobs and contributing to the economic benefit and development of the Penticton area.”

Green Mountain is currently mid-stage of Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) process.

About Green Mountain Health Alliance Ltd.: Green Mountain Health Alliance Ltd. (GMHA) is a capacity wholesale medical cannabis company, developing large-scale, low-cost production facilities in the Okanagan, B.C. The Company has applied to become a licensed cultivator, processor, and distributor of medical cannabis within Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”).

As a wholesale producer, GMHA aims to fill a gap in the Canadian cannabis market, effectively eliminating retail risk. The company has secured over 100 acres with the potential for over 1,000,000 square feet of growing space. The first site will be on a 16-acre parcel, located in Canada’s best growing area, the Okanagan.

Green Mountain’s experienced team and strong partnerships are focused on the cost-effective and efficient production of medical cannabis. The company is committed to best in class practices for low energy and sustainable production.

Grow Green.

The information contained herein contains “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements relate to information that is based on assumptions of management, forecasts of future results, and estimates of amounts not yet determinable. Any statements that express predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements.”  Forward-looking statements are subject to a variety of risks and uncertainties that could cause actual events or results to differ from those reflected in the forward-looking statements. Investors are cautioned against attributing undue certainty to forward-looking statements. These forward-looking statements are made as of the date hereof, and the Company does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from the Company’s expectations or projections.

For further information:
Wade Attwood
President
wattwood@greenmountainhealthalliance.com
Dave Coolidge
VP Business Development
dcoolidge@greenmountainhealthalliance.com
Tel: (250) 486-5454
www.greenmountainhealthalliance.com

Source: www.newsfilecorp.com

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press releases dated July 21, 2020 and July 31, 2020, the Company proposes to amend the exercise price of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

The Company had initially proposed a lower amended price, but that proposal was not approved by the TSX Venture Exchange (“Exchange“), however, the Exchange indicated that a $0.10 exercise price, may be more acceptable. Accordingly, the proposed amendment remains subject to Exchange approval.

Keep reading... Show less

Issuance of U.S. Patent No. 10,851,077 covering methods for extracting and concentrating cannabinoids using ultrasound-enhanced solvent extraction bolsters World Class’ intellectual patent portfolio

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announced the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 10,851,077 on December 1, 2020 in relation to the Company’s methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction

Keep reading... Show less

Ubican brings well-known brands and is a trusted vendor with an established sales and marketing program

Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”), announces Ubican Global (“Ubican”) as its primary supplier for its United States VICKI program. Ubican is a trusted supplier of a family of brands, each with multiple types of products. The products include tinctures, digestibles, edibles, pet, beautyskincare, topical, edible, fitness, and smokable products

Keep reading... Show less